List of Tables
Table 1. Cell and Gene Therapy Drug Delivery Devices Market Trends
Table 2. Cell and Gene Therapy Drug Delivery Devices Market Drivers & Opportunity
Table 3. Cell and Gene Therapy Drug Delivery Devices Market Challenges
Table 4. Cell and Gene Therapy Drug Delivery Devices Market Restraints
Table 5. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cell and Gene Therapy Drug Delivery Devices Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell and Gene Therapy Drug Delivery Devices Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Therapy Drug Delivery Devices
Table 10. Global Cell and Gene Therapy Drug Delivery Devices Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cell and Gene Therapy Drug Delivery Devices Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region (2019-2024) & (%)
Table 27. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cell and Gene Therapy Drug Delivery Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cell and Gene Therapy Drug Delivery Devices Sales Value, (2025-2030) & (US$ Million)
Table 31. Amgen, Inc. Basic Information List
Table 32. Amgen, Inc. Description and Business Overview
Table 33. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Amgen, Inc. (2019-2024)
Table 35. Amgen, Inc. Recent Developments
Table 36. Bausch and Lomb Incorporated Basic Information List
Table 37. Bausch and Lomb Incorporated Description and Business Overview
Table 38. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Bausch and Lomb Incorporated (2019-2024)
Table 40. Bausch and Lomb Incorporated Recent Developments
Table 41. Becton, Dickinson and Company Basic Information List
Table 42. Becton, Dickinson and Company Description and Business Overview
Table 43. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Becton, Dickinson and Company (2019-2024)
Table 45. Becton, Dickinson and Company Recent Developments
Table 46. Bluebird bio, Inc. Basic Information List
Table 47. Bluebird bio, Inc. Description and Business Overview
Table 48. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Bluebird bio, Inc. (2019-2024)
Table 50. Bluebird bio, Inc. Recent Developments
Table 51. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Basic Information List
Table 52. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Description and Business Overview
Table 53. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) (2019-2024)
Table 55. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
Table 56. Dendreon Pharmaceuticals LLC. Basic Information List
Table 57. Dendreon Pharmaceuticals LLC. Description and Business Overview
Table 58. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Dendreon Pharmaceuticals LLC. (2019-2024)
Table 60. Dendreon Pharmaceuticals LLC. Recent Developments
Table 61. Helixmith Co., Ltd (ViroMed Co., Ltd) Basic Information List
Table 62. Helixmith Co., Ltd (ViroMed Co., Ltd) Description and Business Overview
Table 63. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Helixmith Co., Ltd (ViroMed Co., Ltd) (2019-2024)
Table 65. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
Table 66. Human Stem Cell Institute Basic Information List
Table 67. Human Stem Cell Institute Description and Business Overview
Table 68. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Human Stem Cell Institute (2019-2024)
Table 70. Human Stem Cell Institute Recent Developments
Table 71. Kite Pharma, Inc. Basic Information List
Table 72. Kite Pharma, Inc. Description and Business Overview
Table 73. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Kite Pharma, Inc. (2019-2024)
Table 75. Kite Pharma, Inc. Recent Developments
Table 76. Kolon Tissue Gene, inc. Basic Information List
Table 77. Kolon Tissue Gene, inc. Description and Business Overview
Table 78. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Kolon Tissue Gene, inc. (2019-2024)
Table 80. Kolon Tissue Gene, inc. Recent Developments
Table 81. Novartis AG Basic Information List
Table 82. Novartis AG Description and Business Overview
Table 83. Novartis AG Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Novartis AG (2019-2024)
Table 85. Novartis AG Recent Developments
Table 86. Orchard Therapeutics plc. Basic Information List
Table 87. Orchard Therapeutics plc. Description and Business Overview
Table 88. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Orchard Therapeutics plc. (2019-2024)
Table 90. Orchard Therapeutics plc. Recent Developments
Table 91. Pfizer, Inc. Basic Information List
Table 92. Pfizer, Inc. Description and Business Overview
Table 93. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Pfizer, Inc. (2019-2024)
Table 95. Pfizer, Inc. Recent Developments
Table 96. Renova Therapeutics Basic Information List
Table 97. Renova Therapeutics Description and Business Overview
Table 98. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Renova Therapeutics (2019-2024)
Table 100. Renova Therapeutics Recent Developments
Table 101. Spark Therapeutics, Inc. Basic Information List
Table 102. Spark Therapeutics, Inc. Description and Business Overview
Table 103. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Spark Therapeutics, Inc. (2019-2024)
Table 105. Spark Therapeutics, Inc. Recent Developments
Table 106. uniQure N.V. Basic Information List
Table 107. uniQure N.V. Description and Business Overview
Table 108. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of uniQure N.V. (2019-2024)
Table 110. uniQure N.V. Recent Developments
Table 111. Vericel Corporation Basic Information List
Table 112. Vericel Corporation Description and Business Overview
Table 113. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Products, Services and Solutions
Table 114. Revenue (US$ Million) in Cell and Gene Therapy Drug Delivery Devices Business of Vericel Corporation (2019-2024)
Table 115. Vericel Corporation Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Cell and Gene Therapy Drug Delivery Devices Downstream Customers
Table 119. Cell and Gene Therapy Drug Delivery Devices Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cell and Gene Therapy Drug Delivery Devices Product Picture
Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 4. Cell and Gene Therapy Drug Delivery Devices Report Years Considered
Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2023
Figure 7. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Sterile Insulin Syringe Picture
Figure 9. Pre-Filled Syringe Picture
Figure 10. Infusion Bags Picture
Figure 11. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Cell and Gene Therapy Drug Delivery Devices Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Luxturna
Figure 14. Product Picture of Kymriah
Figure 15. Product Picture of Provenge
Figure 16. Product Picture of Zolgensma
Figure 17. Product Picture of Yescarta
Figure 18. Product Picture of Strimvelis
Figure 19. Global Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Cell and Gene Therapy Drug Delivery Devices Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Cell and Gene Therapy Drug Delivery Devices Sales Value (%), (2019-2030)
Figure 32. United States Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 38. China Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 40. China Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 50. India Cell and Gene Therapy Drug Delivery Devices Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Cell and Gene Therapy Drug Delivery Devices Sales Value by Type (%), 2023 VS 2030
Figure 52. India Cell and Gene Therapy Drug Delivery Devices Sales Value by Application (%), 2023 VS 2030
Figure 53. Cell and Gene Therapy Drug Delivery Devices Industrial Chain
Figure 54. Cell and Gene Therapy Drug Delivery Devices Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
